The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Dynamic HER2-low status among patients with triple negative breast cancer (TNBC): The impact of repeat biopsies.
 
Yael Bar
No Relationships to Disclose
 
Aylin S. Dedeoglu
No Relationships to Disclose
 
Geoffrey G. Fell
No Relationships to Disclose
 
Natalie J. Moffett
No Relationships to Disclose
 
Baris Boyraz
No Relationships to Disclose
 
Amy Ly
No Relationships to Disclose
 
Aditya Bardia
Consulting or Advisory Role - bioTheranostics; Daiichi Sankyo/Astra Zeneca; Foundation Medicine; Genentech; Genentech/Roche (Inst); Immunomedics; Immunomedics (Inst); Innocrin Pharma (Inst); Merck; Novartis; Novartis (Inst); Pfizer; Pfizer (Inst); Philips Healthcare; Puma Biotechnology; Radius Health; Radius Health (Inst); Sanofi; Spectrum Pharmaceuticals
Research Funding - AstraZeneca/Daiichi Sankyo (Inst); Genentech (Inst); Immunomedics (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Radius Health (Inst); Sanofi (Inst)
 
Beverly Moy
Consulting or Advisory Role - HRA Pharma
 
Leif W. Ellisen
Consulting or Advisory Role - Gilead Sciences; KisoJi Biotechnology; mersana
 
Steven J. Isakoff
Employment - Merus (I)
Stock and Other Ownership Interests - Merus NV (I)
Consulting or Advisory Role - Paxman
Research Funding - Abbvie (Inst); AstraZeneca/MedImmune (Inst); Genentech (Inst); Merck (Inst); OncoPep (Inst); Outcomes4Me (Inst)